Singapour : révision des frais réglementaires pour les produits de santé

On 1 December 2021, The Health Sciences Authority (HSA) revised the fee for health products.

These fees will help cover the cost of registration, licensing, notification and permit issuance for therapeutic products, medical devices, Chinese proprietary medicines, cosmetic products, oral dental gums and retail pharmacies.

With effect from 1 July 2022, a fee increase averaging 3% will be implemented, with a minimum increase of $1 and capped at $200 per fee item. This fee revision is necessary to recover part of the costs for the services rendered to businesses.

The revised fees cover the following categories and can be found on the HSA website:

• Dispositifs médicaux
• Therapeutic Products
• Medicinal Products, Active Pharmaceutical Ingredients, Controlled Drugs and Psychotropic Substances
• Chinese Proprietary Medicines
• Cosmetic Products
• Retail Pharmacy Licence
• Medical Advertisements & Sales Promotion

Besoin d’en savoir plus sur les changements réglementaires relatifs aux dispositifs médicaux ? Contactez les experts de RegASK.